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Abstract
Background: Many plants of genus Cordia are traditionally used as astringent, anti-inflammatory, anthelminthic,
antimalarial, diuretic, febrifuge, appetite suppressant and cough suppressant and to treat urinary infections, lung
diseases and leprosy. The aim of the study is to determine the total phenolic and flavonoid contents of total
ethanol extract and different fractions of C. myxa L. leaves, in addition to evaluation of some pharmacological
activities including antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic effects.
Methods: Air dried powder of C. myxa leaves were extracted using 95% ethanol and fractionated successively with
petroleum ether, dichloromethane, ethyl acetate and finally with n-butanol. The fractions were concentrated and
then investigated for their antioxidant, anti-inflammatory, analgesic, antipyretic and antidiabetic activities using
phosphomolybidinum and DPPH assays, carrageenan-induced paw edema, hot plate, yeast -induced pyrexia and
streptozotocin-induced hyperglycemia methods, respectively.
Results: The ethyl acetate fraction showed the highest antioxidant activity with high phenolic and flavonoid
contents (31.03 ± 0.15 mg gallic acid equivalent/g dried weight and 811.91 ± 0.07 mg rutin equivalent/g dried
weight, respectively). Dichloromethane and ethyl acetate fractions exhibited higher anti-inflammatory activity
with percentages of inhibition 45.16% and 40.26%, respectively, which were quite comparable to that of
indomethacin (51.61%). The petroleum ether and dichloromethane fractions showed the highest analgesic
activity with reaction time 289.00 ± 3.00 and 288.33 ± 20.82, respectively. Evaluation of antipyretic activity
revealed that the total ethanol extract and different fractions showed high antipyretic activities after 2 h,
which were very close to that of the standard acetyl salicylic acid with a rapid onset (30 min). The total
ethanol extract and the petroleum ether fraction exhibited the most potent hypoglycemic effect with a
significant reduction in blood glucose level especially after 3 h to 95.67 ± 5.77 mg/dl and 87.67 ± 10.26 mg/dl,
respectively and percentages decrease in blood glucose level were 68.22% and 70.78%, respectively.
Conclusion: Cordia myxa L. extract and fractions exhibited antioxidant, anti-inflammatory analgesic, antipyretic
and antidiabetic activities which may be attributed by the presence of active phytoconstituents.
Keywords: Boraginaceae, Cordia myxa, Total phenolics, Total flavonoids, Antioxidant, Anti-inflammatory,
Analgesic, Antipyretic, Antidiabetic
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Background
Boraginaceae (borage) family comprises about 2740 spe-
cies distributed in 148 genera [1]. Various chemical con-
stituents isolated and characterized from Boraginaceous
plants, including pyrrolizidine alkaloids, naphthaqui-
nones, flavonoids, terpenoids, triterpenoids and phenols
[2]. Cordia is an important and representative genus of
this family that could grow as trees, shrubs or sometimes
subscandents [1]. The generic name honours a sixteenth
century botanist, Valerius Cordus [3]. The genus Cordia
originates from tropical and subtropical regions. About
300 species have been identified worldwide, mostly in
the warmer regions. Cordia myxa (Syn. Cordia obliqua,
Cordia crenata) is a medium sized deciduous tree about
10.5 m [4]. The chemical characteristics of this genus are
the presence of quinones which are known as cordiaqui-
nones [1]. Pyrrolizidine alkaloids are generally present as
esters. More than 200 pyrrolizidine alkaloids have been
isolated from these plants. Although these alkaloids are
cytotoxic and cause poisoning, Cordia myxa was reported
to contain the nontoxic alkaloid macrophylline [2].
The plant parts like fruits, leaves, stem bark, seeds and
roots of most species of this genus, especially Cordia
dichotoma, C. myxa, C. verbenacea, C. martinicensis, C.
salicifolia, C. spinescens, C. latifolia, C. ulmifolia, among
others, have long been used in traditional medicine as
astringent, anti-inflammatory, anthelminthic, antimalar-
ial, diuretic, febrifuge, appetite suppressant and cough
suppressant and to treat urinary infections, lung diseases
and leprosy. Cordia myxa fruits and seeds are also used
as expectorants and effective in treating the diseases of
the lungs. Raw fruits contain a gum which can be used
beneficially in gonorrhea. They can remove pain from
the joints and the burning of the throat, effective in
treating the diseases of the spleen, and are used as a de-
mulcent in southern Iran [1]. For this reasons the current
study evaluate some pharmacological activities of total
ethanol extract and different fractions of C. myxa L. leaves
including antioxidant, anti-inflammatory, analgesic, anti-
pyretic, antidiabetic and antimalarial effects.
Methods
Plant material
The leaves of C. myxa were collected from May to No-
vember 2015 from El-Orman botanical garden, Cairo,
Egypt and identified by Prof. Dr. Nasser Barakat, Professor
of Botany, Faculty of Science, Minia University. A voucher
sample (Mn-Ph-Cog-023) was kept in the Herbarium of
Pharmacognosy Department, Faculty of Pharmacy, Minia
University, Minia, Egypt.
Preparation of the extract and fractions
The air dried powdered leaves (4.24 Kg) of C. myxa.
Were extracted by maceration with 95% ethanol at room
temperature with occasional agitation for 7 days till ex-
haustion, and then concentrated under reduced pressure
till dryness. The concentrated ethanol extract (275 g)
was suspended in the least amount of distilled water,
transferred to a separating funnel and partitioned suc-
cessively by liquid/liquid extraction with petroleum
ether, dichloromethane, ethyl acetate and finally with n-
butanol. The fractions were concentrated under reduced
pressure at 40 °C to afford petroleum ether (107 g), di-
chloromethane (13.2 g), ethyl acetate (11.74 g) and n-bu-
tanol (49.92 g) fractions.
Animals
The animals used in this study include female and male
albino rats weighing 200 ± 50 g and mice weighing 30 ±
5 g, obtained from animal house of Faculty of Medicine,
Assiut University. They were housed under standardized
environmental conditions, and fed with standard diet
and water. The study was conducted following approval
by the Institutional Animal Ethical Committee of Faculty
of Pharmacy, Minia University, Minia, Egypt.
Acute toxicity
The acute toxicity of the total ethanolic extract of Cordia
myxa leaves was evaluated by measuring the lethal dose
for 50% of the laboratory animals (LD50) [5]. Different
dose levels (1, 2, 2.5, 3 up to 3.5 g/ kg, p.o) of the total
ethanolic extract (suspended in 0.5% CMC) were orally
administrated to different groups of mice (30 ± 5 g, each
containing six mice). The control group received an
equivalent dose of the vehicle (0.5% CMC). Both the test
and control groups were noticed for 24 h under normal
environmental conditions, with free access to food and
water.
Evaluation of antioxidant study
Each sample was dissolved in 95% methanol to make a
concentration of 40 mg/ml from total ethanolic extract
and different fractions except the ethyl acetate fraction
which was prepared as 10 mg/ml and then diluted to
prepare the series concentrations for antioxidant assays.
Estimation of total phenolic content
The content of total phenolic compounds for total etha-
nol extract and different fractions of C. myxa leaves
were determined by Folin–Ciocalteu method [6]. Ana-
lysis was performed by adding 3.5 ml of deionized water,
50 μl of sample extract, 50 μl Folin-Ciocalteu reagent (2
N) and 300 μl of sodium carbonate (10%). The reaction
was left for 30 min. and then the absorbance was
measured in triplicate at 730 nm. The blank consisted of
all reagents excluding the sample extract. A standard
curve was made using gallic acid so that total phenolic
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concentration was expressed as mg of gallic acid equiva-
lents per gram dried fraction.
Estimation of total flavonoid content
Total flavonoid content was determined following a
method in literature [6], where 0.3 ml of extracts, 3.4
ml of 30% methanol, 0.15 ml of NaNO2 (0.5 M) and
0.15 ml of AlCl3.6H2O (0.3 M) were mixed. After 5
min, 1 ml of NaOH (1M) was added. The solution
was mixed well and the absorbance was measured in
triplicate against the reagent blank at 506 nm. The
standard curve for total flavonoids was made using rutin
standard solution at different concentration under the same
procedure. The total flavonoid content was expressed
as milligrams of rutin equivalents per gram of dried
fraction.
Phosphomolybdate assay (total antioxidant capacity)
The total antioxidant capacity of the fractions was deter-
mined by phosphomolybdate method using ascorbic acid as
a standard [6]. An aliquot of 0.3ml of sample solution was
mixed with 3ml of reagent solution (0.6M sulphuric acid,
28mM sodium phosphate and 4mM ammonium molyb-
date). The tubes were capped and incubated in a water bath
at 95 °C for 90min. After the samples had cooled to room
temperature, the absorbance of the mixture was measured
at 695 nm against a blank. A typical blank contained 3ml
of the reagent solution and the appropriate volume of the
solvent and incubated under the same conditions. A stand-
ard curve was made using ascorbic acid; hence, the antioxi-
dant activity was expressed relative to that of ascorbic acid.
All determinations were done in triplicate.
DPPH radical scavenging activity assay
The free radical scavenging activity of the fractions was
measured using 1,1- diphenyl-2-picryl-hydrazyl (DPPH)
[6]. Briefly, 200 μl of each of the extract or fractions at
various concentrations was added to 2 ml of DPPH
solution (0.1 mM), The reaction mixture was shaken well
and incubated in the dark for 15min at room temperature.
Methanol was used instead of the extract and fractions as a
control. Then the absorbance was measured in triplicate at
517 nm. The capability to scavenge the DPPH radical was
calculated using the following equation:
DPPH scavenging effect (%) = [(A0 -A1/A0) × 100].
Where A0 was the absorbance of the control reaction
and A1 equal the absorbance in the presence of the ex-
tract. The extract concentration providing 50% inhib-
ition (IC50) was calculated from the graph of DPPH
scavenging effect against extract concentration.
Anti-inflammatory activity
The total ethanol extract and different fractions of C.
myxa leaves were evaluated for their anti-inflammatory
activity using the carrageenan-induced paw edema
method [7]. Female albino rats (200 ± 50 g) were ran-
domly divided into seven groups (six animals per group).
The specified dose of extract, fractions, and standard
drug were suspended in 0.5% CMC solution. The –ve
control group administered the vehicle (0.5% CMC solu-
tion), while the standard drug indomethacin (+ve con-
trol) was given orally at a dose level of 8 mg/kg. The
total ethanol extract and different fractions were admin-
istered orally at a dose of 350mg/kg through 2 h after
carrageenan injection 0.1 ml, 1% w/v in normal saline,
s.c.) into the sub-plantar tissue of the right hind paw.
The paw thickness (mm) was measured using a vernier
calliper at 0, 0.5, 1, 2, 3, 4 and 5 h after administration of
the tested extract, fractions and standard drug. The per-
centage inhibition of the rat paw edema was calculated
as follows [8]:




The analgesic activity of the total ethanol extract and
different fractions of C. myxa L. leaves was evaluated
using hot plate method [9]. Mice (30 ± 5 g) were grouped
into seven groups (six animals each). The –ve control
group administered the vehicle (0.5% CMC solution)
and the standard drug paracetamol 100 mg/kg, p.o. (+ve
control). The tested extract and different fractions were
Table 1 Results representing the total phenolic content of the total ethanol extract and the different fractions of C. myxa L. leaves
using Folin–Ciocalteu method
Extract or fraction Total extract Petroleum ether fraction Dichloromethane fraction Ethyl acetate fraction n-Butanol fraction
Total phenolic content
(mg/g gallic acid equivallent)
5.76 ± 0.23 4.75 ± 0.22 8.81 ± 0.04 31.03 ± 0.15 4.54 ± 0.04
Table 2 Results representing the total flavonoid content of the total ethanol extract and the different fractions of C. myxa L. leaves
Extract or fraction Total extract Petroleum ether fraction Dichloromethane fraction Ethyl acetate fraction n-Butanol fraction
Total flavonoidal content
(mg/g rutin equivallent)
192.24 ± 0.33 13.09 ± 0.11 295.45 ± 0.13 811.91 ± 0.07 84.29 ± 0.017
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suspended in 0.5% CMC solution and were administered
orally at a dose level of 350 mg/kg. The animals were
placed on a hot plate and the temperature of the metal
surface was maintained at 54 °C. The time (sec) of the
response produced by the animal as tail withdrawn, lick-
ing paws or jumping due to radient heat is noted and re-
corded at 0, 0.5, 1, 2, 3, 4 and 5 h after the
administration of the tested extract, fractions and the
standard drug.
The percentage of protection against thermal stimulus
was calculated as follows [10]:
%protection against thermal stimulus
¼ Test mean Tað Þ‐Control mean Tbð Þ
Control mean Tbð Þ X 100
Antipyretic activity
The total ethanol extract and different fractions of C.
myxa L. leaves were evaluated for their antipyretic ac-
tivity using yeast-induced pyrexia method [11, 12]. The
test was performed on female albino rats (200 ± 50 g)
by subcutaneous injection (in the back, below the nape
of the neck) of 20% aqueous suspension of yeast in a
dose of 10 ml/kg to induce pyrexia. The pyretic animals
were grouped into seven groups (six animals each). The
–ve control group orally administered the vehicle (0.5%
CMC solution), while the +ve control was given the ref-
erence drug acetylsalicylic acid at a dose level of 330
mg/kg, p.o). The tested extract and different fractions
were suspended in 0.5% CMC solution and were ad-
ministered orally at a dose level of 350 mg/kg through
2 h after yeast injection. The rectal temperature of each
animal was recorded by inserting a thermometer 2 cm
into the rectum at 0, 0.5, 1, 2, 3, 4 and 5 h following the
administration of the tested extract, fractions and the
reference drug.
Anti-diabetic activity
The total ethanol extract and different fractions of C.
myxa L. leaves were evaluated for their anti-diabetic ef-
fects using streptozotocin-induced hyperglycemia method
[12]. The test was performed on adult male albino rats
(200 ± 50 g) by intraperitoneal injection of streptozotocin
(80mg/kg). Blood glucose level was measured after 3 days
up to 1 week for assessment of hyperglycemia. Rats with
blood glucose level above (200 mg/dl) were consid-
ered to be diabetic and were used in this study. The
diabetic rats were divided into seven groups (six rats
each). The control group was administered the ve-
hicle (0.5% CMC solution) and the standard drug
vildagliptin 50 mg/kg p.o. (+ve control). The tested
extract and different fractions were suspended in
0.5% CMC solution and were orally administered at
a dose level of 350 mg/kg. Blood glucose levels were
measured at intervals of 0 (fasting), 0.5, 1, 2, 3, 4
and 5 h by collecting blood samples from the tail
vein (caudal vein). The percentage of change in
blood glucose level was calculated by the following
formula [12, 13]:
%lowering of blood glucose level
¼ Wc fastingð Þ−Wt testð Þ
Wc fastingð Þ X 100
Statistical analysis
Results of all biological studies were expressed as means
± S.E.M. One-way analysis of variance (ANOVA) follo-
wedby Dunnett’s test was used to determine significance
when compared to the control group. p values less than
0.05, 0.01, and 0.001 were considered significant (*p <
0.05, **p < 0.01,*** p < 0.001). Graph Pad Prism 5 was
used for statistical calculations (Graph pad Software, San
Diego California, USA).
Table 3 Results of the total antioxidant capacities of the total ethanol extract and the different fractions of C. myxa L. leaves using
phosphomolybdate assay
Extract or fraction Total extract Petroleum ether fraction Dichloromethane fraction Ethyl acetate fraction Butanol fraction
Free radical scavenging activity 24.50 ± 0.37 26.35 ± 0.31 27.05 ± 0.28 103..40 ± 0.05 12.58 ± 0.60











IC50 1.33 ± 0.03 mg/
ml
1.21 ± 0.21 mg/ml 1.03 ± 0.06 mg/ml 0.03 ± 0.01 mg/ml 1.28 ± 0.10 mg/
ml
0.96 ± 0.03 μg/
ml
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Results
Acute toxicity
Concerning the safety of C. myxa L. plant, a preliminary
toxicity study showed no mortality up to a dose level of
2500 mg/Kg and this was in accordance with published
data which reported that both the leaves and the fruits
are safe and edible in India and other countries [14, 15].
Evaluation of antioxidant study
Estimation of total phenolic content
The content of total phenolic compounds of the total
ethanol extract and the different fractions of C. myxa L.
leaves was determined by Folin– Ciocalteu method. The
results were shown in Table 1 and Additional file 1.
Results were varied widely, ranging from 4.54 ± 0.04 to
31.03 ± 0.15 mg gallic acid equivalent/g dried weight.
The highest amount of phenols was found in the ethyl
acetate fraction (31.03 ± 0.15), followed by the dichloro-
methane, total extract, petroleum ether and n-butanol
fractions (8.81 ± 0.04), (5.76 ± 0.23), (4.75 ± 0.22) and
(4.54 ± 0.04), respectively.
Estimation of total flavonoid content
The total flavonoid content of the total ethanol extract and
different fractions of C. myxa L. leaves was determined and
the results were shown in Table 2 and Additional file 2,
where they varied widely, ranging from 13.09 ± 0.11 to
811.91 ± 0.07mg rutin equivalent/g dried weight. The high-
est amounts of flavonoids was.
found in the ethyl acetate fraction (811.91 ± 0.07)
followed by the dichloromethane fraction (295.45 ±
0.13), the total extract (192.24 ± 0.33), the n-butanol
fraction (84.29 ± 0.017) and lastly the petroleum ether
fraction which contained remarkably lower amounts of
these compounds (13.09 ± 0.11).
Phosphomolybdate assay (total antioxidant capacity)
The total ethanol extract and the different fractions of
C. myxa L. leaves showed varied antioxidant capacity.
The highest antioxidant capacity was displayed by the
ethyl acetate fraction (103.40 ± 0.05) mg of ascorbic acid
equivalent/g dried weight. The other fractions and the
total ethanol extract showed mild antioxidant capacities,
where the butanol fraction showed the lowest capacity
(12.58 ± 0.60) mg of ascorbic acid equivalent/g dried
fraction. The results of phosphomolybdate assay were
listed in Table 3 and illustrated in Additional file 3.
DPPH radical scavenging activity assay
By analyzing the antioxidant activity of the total ethanol ex-
tract and the different fractions of C. myxa L. leaves, it was
demonstrated that all showed dose-dependent antioxidant
Table 5 Results of the anti-inflammatory activity of the total ethanol extract and the different fractions of C. myxa L. leaves using
carrageenan-induced paw edema method
Group Thickness of the paw (mm)
0 h 30min 1 h 2 h 3 h 4 h 5 h
Control (−ve) 7.38 ± 0.25 7.25 ± 0.29 7.25 ± 0.29 7.63 ± 0.25 7.75 ± 0.29 7.75 ± 0.29 7.75 ± 0.29
Total extract (350mg/kg) 7.25 ± 0.29 7.00 ± 0.00 6.50 ± 0.41 * 6.25 ± 0.29 *** 6.00 ± 0.41 *** 6.25 ± 0.29 *** 6.75 ± 0.29 **
Petroleum ether fraction (350mg/kg) 7.25 ± 0.29 7.13 ± 0.25 6.88 ± 0.25 6.75 ± 0.29 *** 6.63 ± 0.48** 6.38 ± 0.25 *** 7.13 ± 0.25 *
Dichloromethane fraction (350 mg/kg) 7.00 ± 0.00 * 7.00 ± 0.00 6.38 ± 0.48 * 5.75 ± 0.29 *** 4.63 ± 0.75 *** 4.25 ± 0.29 *** 5.63 ± 0.48 ***
Ethyl acetate fraction (350 mg/kg) 7.38 ± 0.25 7.13 ± 0.25 6.63 ± 0.48 6.13 ± 0.48 ** 5.50 ± 0.41 *** 4.63 ± 0.48 *** 6.00 ± 0.41 ***
Butanol fraction (350 mg/kg) 7.25 ± 0.29 7.13 ± 0.25 6.75 ± 0.29 * 6.50 ± 0.41 ** 6.38 ± 0.25 *** 5.755 ± 0.29 *** 6.50 ± 0.41 **
Indomethacin (8 mg/kg) 7.25 ± 0.29 6.88 ± 0.25 5.25 ± 0.65 *** 3.88 ± 0.25 *** 3.75 ± 0.29 *** 3.75 ± 0.29 *** 5.75 ± 0.29 ***
The results are presented as the mean ± S.E.M. (Standard error of the mean). Differences with respect to the control group were calculated using the student’s T-
test (*P > 0.05, **P < 0.01, ***P < 0.001)





Percentages of inhibition (%)
30 min 1 h 2 h 3 h 4 h 5 h
Total extract 350 3.45 10.34 18.09 22.58 19.35 12.90
Petroleum ether fraction 350 1.66 5.10 11.53 14.45 17.68 8
Dichloromethane fraction 350 3.45 12 24.64 40.26 45.16 27.35
Ethyl acetate fraction 350 1.66 8.55 19.66 29.03 40.26 22.58
Butanol fraction 350 1.66 6.90 14.81 17.68 25.81 16.13
Indomethacin 8 5.10 27.59 49.15 51.61 51.61 25.81
Abdel-Aleem et al. Clinical Phytoscience            (2019) 5:29 Page 5 of 9
activity. Results were listed in Table 4 and illustrated in
Additional file 4. The ethyl acetate fraction was the
most effective DPPH free radical scavenger with IC50
with a value of 0.03 ± 0.01 mg/ml. The other fractions
and the total ethanol extract showed higher IC50, thus
lower DPPH radical scavenging activity, where the
total ethanol extract exhibited the lowest DPPH rad-
ical scavenging activity with IC50 value of 1.33 ± 0.03
mg/ml as compared with BHT (0.96 ± 0.03 μg/ml) as a
positive control.
Anti-inflammatory activity
It is obvious from Tables 5 and 6 and Additional file 5
that the percentages of edema inhibition varied within
the different fractions and the total extract. A gradual in-
crease was observed for the first 4 h, then, the activity
started to decline again. The highest anti-inflammatory
activity was observed after 3 h in the total extract and
after 4 h for the rest of the fractions, while the standard
showed this activity after both the third and fourth hour
from administration. After 3 h, the dichloromethane
fraction showed moderate anti-inflammatory activity
with a percentage of inhibition (40.26%), while, after 4 h,
both the dichloromethane and the ethyl acetate fractions
showed higher anti-inflammatory activity with percent-
ages of inhibition (45.16%) and (40.26%), respectively,
which were quite comparable to that of indomethacin
(51.61%). The total extract and the butanol fraction
showed mild inhibition of the inflammation that was in-
creased by time to be 19.35% and 25.81%, respectively,
after 4 h. On the other hand, the least activity was shown
by the petroleum ether fraction throughout the 5 h of
the experiment.
Analgesic activity
The results of the analgesic activity of the total ethanol
extract and different fractions of C. myxa L. leaves re-
vealed that the total ethanol extract and all fractions ex-
hibited potent analgesic activity compared to the control
but less than the used standard paracetamol (Tables 7
and 8 and Additional file 6). One hour from the begin-
ning of the experiment, the total ethanol extract, petrol-
eum ether and dichloromethane fractions significantly
increased the reaction time (106.33 ± 3.06***), (191.00 ±
Table 7 Results of the analgesic activity of the total ethanol extract and the different fractions of C. myxa L. leaves in mice using the
hot plate method using paracetamol as a standard
Group Time (sec)
0 h 30min 1 h 2 h 3 h 4 h 5 h
Control (−ve) 87.00 ± 8.32 83.67 ± 7.57 80.33 ± 4.16 69.67 ± 4.16 70.00 ± 3.61 80.67 ± 4.73 81.67 ± 3.06





100.33 ± 4.16* 191.00 ± 31.08** 270.67 ± 8.50*** 289.00 ± 3.00*** 227.00 ± 28.84* 99.00 ± 10.00*
Dichloromethane fraction
(350 mg/kg)
78.67 ± 10.60 86.67 ± 8.08 170.33 ± 21.39** 206.33 ± 16.29*** 288.33 ± 20.82*** 199.67 ± 9.87*** 89.00 ± 13.86
Ethyl acetate fraction (350
mg/kg)
71.00 ± 10.58 91.67 ± 3.06 107.33 ± 11.93* 129.67 ± 2.08*** 139.33 ± 5.69*** 103.33 ± 1.53** 91.33 ± 12.42




83.33 ± 7.37 85.67 ± 13.01 74.33 ± 5.03 74.33 ± 5.03 79.67 ± 2.03 80.33 ± 4.62
Paracetamol (100 mg/kg) 70.67 ± 5.51** 107.67 ± 5.77* 311.00 ± 19.28*** 321.67 ± 25.01*** 386.33 ± 8.08*** 258.33 ± 41.59*** 122.33 ± 15.01**
The results are presented as the mean ± S.E.M. Differences with respect to the control group were calculated using the student’s T-test (*P > 0.05,
**P < 0.01, ***P < 0.001)
Table 8 Results representing the percentage of protection against external stimulus of the total ethanol extract and the different




Percentage of protection against external stimulus (%)
30min 1 h 2 h 3 h 4 h 5 h
Total extract 350 12.74 32.37 87.56 100.96 59.08 24.07
Petroleum ether fraction 350 19.91 137.77 288.50 312.86 181.39 21.22
Dichloromethane fraction 350 3.59 112.04 196.15 311.90 147.51 8.98
Ethyl acetate fraction 350 9.56 33.61 86.12 99.04 28.09 11.83
Butanol fraction 350 −0.4 6.65 6.69 6.19 −1.2 −1.6
Paracetamol 100 28.68 287.15 361.71 451.43 220.23 49.79
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31.08**) and (170.33 ± 21.39**), respectively. After 3 h,
the petroleum ether and dichloromethane fractions
showed the highest analgesic activity (289.00 ± 3.00***)
and (288.33 ± 20.82***), respectively. They increased the
reaction time more than three times as that of the –ve
control. The total extract showed moderate analgesic ac-
tivity. It increased the reaction time double that of the
control. The ethyl acetate and butanol fractions showed
slight analgesic activities compared to other fractions.
Antipyretic activity
The results of the antipyretic activity of the total ethanol
extract and different fractions of C. myxa L. leaves re-
vealed that the total ethanol extract and most of the
fractions exhibited a significant (p < 0.001) antipyretic
activity up to 4 h (Table 9 and Additional file 7). After 2
h, the total ethanol extract, the petroleum ether, the
dichloromethane and the ethyl acetate fractions showed
high antipyretic activities which were very close to that
of the standard acetyl salicylic acid with a rapid onset
(30 min). The antipyretic activity lasted up to 4 h. The
butanol fraction showed antipyretic activity with a
slower onset after 2 h which also lasted for 4 h.
Anti-diabetic activity
From the mentioned results in (Tables 10 and 11 and
Additional file 8) the total ethanol extract and petroleum
ether fraction showed potent anti-diabetic effect with a
significant decrease in blood glucose level with a rapid
onset (30 min). Their effects were increased gradually
until reaching the highest level after 3 h, and then a
gradual decline was demonstrated for the rest of experi-
ment. The total ethanol extract and the petroleum ether
fraction were the most potent. They showed a significant
Table 9 Results of the anti-pyretic activity of the total ethanol extract and the different fractions of C. myxa L. leaves using yeast-
induced pyrexia method
Group Rectal temperature (°C)
0 h 30min 1 h 2 h 3 h 4 h 5 h
Control (−ve) 39.83 ± 0.10 39.88 ± 0.05 39.88 ± 0.05 39.88 ± 0.05 39.83 ± 0.10 39.88 ± 0.05 39.28 ± 0.09
Total extract (350mg/kg) 39.75 ± 0.13 38.63 ± 0.39
***








Petroleum ether fraction (350mg/
kg)
39.83 ± 0.10 39.20 ± 0.60 38.80 ± 0.34
***






Dichloromethane fraction (350 mg/
kg)










38.88 ± 0.47 **


































The results are presented as the mean ± S.E.M. Differences with respect to the control group were calculated using the student’s T-test (*P > 0.05,
**P < 0.01, ***P < 0.001)
Table 10 Results of the antidiabetic activity of the total ethanol extract and the different fractions of C. myxa L. leaves using
streptozotocin-induced hyperglycemia method and vildagliptin as a standard
Group Blood glucose level (mg/dl)
0 h 30min 1 h 2 h 3 h 4 h 5 h
Control (−ve) 197 ± 7.21 214.33 ± 5.03 214 ± 7.81 212.67 ± 19.66 300.33 ± 2.31 309 ± 4 322.33 ± 13.01
Total extract (350mg/kg) 209 ± 14.42 136 ± 13.45*** 108.33 ± 3.06*** 99.67 ± 1.15*** 95.67 ± 5.77*** 120 ± 1.73*** 224.33 ± 15.01***
Petroleum ether fraction (350
mg/kg)
211 ± 18.33 117 ± 7.21*** 107.67 ± 4.16*** 93.67 ± 7.57*** 87.67 ± 10.26*** 106 ± 6.08*** 237 ± 13.86**
Dichloromethane fraction (350
mg/kg)
213 ± 16.37 213 ± 11.13 163.67 ± 15.01** 121.67 ± 3.06*** 190.33 ± 1.15*** 271 ± 3.46*** 323.67 ± 2.31
Ethyl acetate fraction (350 mg/
kg)
201.67 ± 3.06 205.67 ± 5.03 215 ± 4 216.33 ± 1.15 310.33 ± 1.15** 311.67 ± 8.08 312.33 ± 4.16
Butanol fraction (350 mg/kg) 204.33 ± 5.03 215 ± 5.29 221.67 ± 9.02 268 ± 29.44*** 293.33 ± 7.51 305.33 ± 3.51 327 ± 15.20
Vildagliptin (50 mg/kg) 208.67 ± 7.77 125 ± 12.12*** 102.33 ± 2.31*** 94.67 ± 6.66*** 64 ± 11.36*** 85 ± 15.20*** 178 ± 20.66***
The results are presented as the mean ± S.E.M. Differences with respect to the control group were calculated using the student’s T-test (*P > 0.05,
**P < 0.01, ***P < 0.001)
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reduction in blood glucose level especially after 3 h
95.67 ± 5.77***mg/dl and 87.67 ± 10.26***mg/dl, respect-
ively. Also the percentage decrease in blood glucose level
was (68.22%) and (70.78%), respectively, which demon-
strates their close resemblance to the standard vildaglip-
tin (78.69%). The dichloromethane fraction also showed
a moderate gradual reduction in blood glucose level up
to 121.67 ± 3.06*** mg/dl after 2 h with a percentage de-
crease of (42.79%) while both ethyl acetate and butanol
fractions showed no anti-diabetic activity throughout the
experiment time.
Discussion
Safety of C. myxa was evaluated and results confirmed
the previous published data [14, 15]. The ethyl acetate
fraction showed the highest antioxidant activity com-
pared to the total ethanol extract and other fractions.
This activity may be attributed to its high content of fla-
vonoids and other phenolic compounds as phenyl propa-
noids. The total ethanol extract and dichloromethane
fraction exhibited highest anti-inflammatory activities
compared to indomethacin. Many mechanisms were
proved for anti-inflammatory activity of flavonoids, such
as: inhibition of cyclooxygenase and 5- lipoxygenase
pathways, and inhibition of eicosanoid biosynthesis, to-
gether with their ability to inhibit neutrophil degradation
[16]. The potent antipyretic activity of the total extract
and different fractions of C. myxa L. may be attributed
to its content of flavonoids and sterols [17]. Analgesic
activity may be attributed to their content of sterols
which were reported to have analgesic activity [18]. Fi-
nally; the hypoglycaemic effect is in accordance with re-
ported literature [19] for the total ethanol extract which
proved that the hypoglycemic mechanism is throughout
the inhibition of α-glucosidase enzyme. Thus it can de-
crease blood glucose level or inhibit glucose absorption.
Conclusion
The present study confirmed that total ethanol extract
and different fractions of C. myxa leaves showed signifi-
cant antioxidant, antiinflammatory, analgesic, antipyretic
and antidiabetic activities in different in vitro and in vivo
experimental models, which are in accordance with folk
medicine of many Cordia plants. The presence of high
content of flavonoids and other phenolic compounds in
the ethyl acetate fraction might have some role in the
observed pharmacological activities. In addition, the
acute toxicity does not show any symptoms, changes in
behavior or mortality at 2.5 g/kg doses that indicate a
therapeutic safety for the doses pharmacologically active.
The further detailed investigation is ongoing to deter-
mine the exact bioactive phytoconstituents that are re-
sponsible for those actions of this plant as traditional
medicine. Moreover, it could be a potential source for
discovery of antioxidant, antiinflammatory, analgesic,
antipyretic and antidiabetic drug development.
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Table 11 Results representing the percentage of decrease in of blood glucose level of the total ethanol extract and the different




Percentage of decrease in blood glucose level (%)
0 h 30 min 1 h 2 h 3 h 4 h 5 h
Total extract 350 −6.09 36.54 49.38 53.13 68.22 61.17 30.40
Petroleum ether fraction 350 −7.11 45.41 49.69 55.96 70.78 65.70 26.47
Dichloromethane fraction 350 −16 0.62 23.52 42.79 36.56 12.30 −0.42
Ethyl acetate fraction 350 −2.37 4.04 −0.47 −1.72 −3.44 − 0.64 3.10
Butanol fraction 350 −3.72 −0.31 − 3.58 −26.02 2.22 1.19 −1.45
Vildagliptin 50 −5.90 41.68 52.18 55.49 78.69 72.49 44.78
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